Reply to Skokou, M. Comment on "Keeler et al. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
19 May 2022
Historique:
received: 09 04 2022
accepted: 27 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

In response to our narrative review, which suggested the use of the glutamatergic n-methyl-D-aspartate (NMDA) receptor antagonist ketamine as a potential treatment for anorexia nervosa (AN) [...].

Identifiants

pubmed: 35631260
pii: nu14102119
doi: 10.3390/nu14102119
pmc: PMC9146951
pii:
doi:

Substances chimiques

Ketamine 690G0D6V8H

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Behav Brain Res. 2003 Mar 18;140(1-2):1-47
pubmed: 12644276
J Psychopharmacol. 2018 Mar;32(3):265-275
pubmed: 29444621
Eat Weight Disord. 2022 Jun;27(5):1775-1785
pubmed: 35298791
Nutrients. 2022 May 19;14(10):
pubmed: 35631259
Curr Top Med Chem. 2005;5(1):3-14
pubmed: 15638774
J Clin Psychiatry. 2003 Nov;64(11):1335-41
pubmed: 14658948
Nutrients. 2021 Nov 20;13(11):
pubmed: 34836413
Am J Psychiatry. 2003 Feb;160(2):255-61
pubmed: 12562571
Int J Eat Disord. 2014 Apr;47(3):329-34
pubmed: 24343841
ACS Chem Neurosci. 2019 May 15;10(5):2125-2143
pubmed: 30933466
Psychopharmacology (Berl). 2014 May;231(9):1897-912
pubmed: 24500676
Int J Mol Sci. 2016 Jul 07;17(7):
pubmed: 27399680
J Psychiatr Pract. 2007 Jul;13(4):238-45
pubmed: 17667736
Pharmacol Ther. 2021 Jan;217:107667
pubmed: 32858054
J Clin Psychiatry. 2007 Sep;68(9):1324-32
pubmed: 17915969
Pharmacol Biochem Behav. 2012 Feb;100(4):801-10
pubmed: 21536062
Borderline Personal Disord Emot Dysregul. 2017 Oct 8;4:21
pubmed: 29043085
J Clin Psychiatry. 2003 Dec;64(12):1449-54
pubmed: 14728106
Biol Psychiatry. 2007 May 1;61(9):1039-48
pubmed: 17258690
J Clin Psychiatry. 2015 Jun;76(6):e787-93
pubmed: 26132687
Int J Eat Disord. 2005 Dec;38(4):295-300
pubmed: 16231337

Auteurs

Johanna Louise Keeler (JL)

Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK.

Janet Treasure (J)

Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK.
South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham BR3 3BX, UK.

Mario F Juruena (MF)

South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham BR3 3BX, UK.
Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK.

Carol Kan (C)

Eating Disorder Service, Central and North West London NHS Foundation Trust, 1 Nightingale Place, Kensington & Chelsea, London SW10 9NG, UK.

Hubertus Himmerich (H)

Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK.
South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham BR3 3BX, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH